Literature DB >> 18838881

Tobacco, antioxidant enzymes, oxidative stress, and genetic susceptibility in oral cancer.

Beena P Patel1, Upendra M Rawal, Rakesh M Rawal, Shilin N Shukla, Prabhudas S Patel.   

Abstract

OBJECTIVES: Oral cancer accounts third of all malignancies in India. Tobacco use, the major etiological factor for oral cancer is known to generate free radicals resulting in alterations in antioxidant enzymes like, glutathione-S-transferase (GST), glutathione reductase, superoxide dismutase, catalase, and glutathione peroxidase as well as lipid peroxidation and total thiol. Therefore, it is of fundamental importance to evaluate the role of tobacco and antioxidant enzymes and oxidative stress markers in oral carcinogenesis.
MATERIALS AND METHODS: One hundred forty oral cancer patients and 50 healthy controls, classified as "habitual controls" and "nonhabitual controls" having tobacco habits and no tobacco habits, respectively, were included in the study. Adjacent normal and malignant tissue samples were also collected. Erythrocyte, plasma, and tissue levels of antioxidant enzymes and total thiol were assayed by spectrophotometric methods. GSTM1 genotype was analyzed using polymerase chain reaction.
RESULTS: Antioxidant enzymes were significantly higher whereas glutathione peroxidase and thiol levels were lower in patients as compared with habitual controls. Habitual controls with higher tobacco exposure and lower antioxidant enzymes as well as thiol showed higher risk of oral cancer development. Antioxidant enzymes were higher, whereas catalase and thiol levels were lower in malignant as compared with adjacent normal tissues. Sixty-three percent of the patients showed GSTM1 null genotype.
CONCLUSION: The study showed risk of oral cancer development in habitual controls with lower antioxidant enzymes, lower oxidative stress markers, and higher lifetime tobacco exposure. Individuals with GSTM1 null genotype may be at higher risk of oral cancer development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18838881     DOI: 10.1097/COC.0b013e31816a61da

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  8 in total

1.  The impact of GSTM1/GSTT1 polymorphism for the risk of oral cancer.

Authors:  Maximilian Krüger; Andreas Max Pabst; Benjamin Mahmoodi; Burkhard Becker; Peer Wolfgang Kämmerer; Felix Peter Koch
Journal:  Clin Oral Investig       Date:  2015-01-18       Impact factor: 3.573

Review 2.  Glutathione levels in human tumors.

Authors:  Michael P Gamcsik; Mohit S Kasibhatla; Stephanie D Teeter; O Michael Colvin
Journal:  Biomarkers       Date:  2012-08-20       Impact factor: 2.658

Review 3.  Nitric oxide and cancer: a review.

Authors:  Sheetal Korde Choudhari; Minal Chaudhary; Sachin Bagde; Amol R Gadbail; Vaishali Joshi
Journal:  World J Surg Oncol       Date:  2013-05-30       Impact factor: 2.754

4.  GSTM1 and GSTT1 null polymorphisms and risk of salivary gland carcinoma.

Authors:  Sayaka Kondo; Erich M Sturgis; Fanglin Li; Qingyi Wei; Guojun Li
Journal:  Int J Clin Exp Med       Date:  2009-02-25

5.  Association Studies of HFE C282Y and H63D Variants with Oral Cancer Risk and Iron Homeostasis Among Whites and Blacks.

Authors:  Nathan R Jones; Joseph H Ashmore; Sang Y Lee; John P Richie; Philip Lazarus; Joshua E Muscat
Journal:  Cancers (Basel)       Date:  2015-12-09       Impact factor: 6.639

6.  Free radicals hasten head and neck cancer risk: A study of total oxidant, total antioxidant, DNA damage, and histological grade.

Authors:  A K Singh; P Pandey; M Tewari; H P Pandey; I S Gambhir; H S Shukla
Journal:  J Postgrad Med       Date:  2016 Apr-Jun       Impact factor: 1.476

Review 7.  Redox theory of aging: implications for health and disease.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Clin Sci (Lond)       Date:  2017-06-30       Impact factor: 6.124

8.  Tobacco and oral squamous cell carcinoma: A review of carcinogenic pathways.

Authors:  Xiaoge Jiang; Jiaxin Wu; Jiexue Wang; Ruijie Huang
Journal:  Tob Induc Dis       Date:  2019-04-12       Impact factor: 2.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.